First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours.
Yap TA, Cortes-Funes H, Shaw H, Rodriguez R, Olmos D, Lal R, Fong PC, Tan DS, Harris D, Capdevila J, Coronado C, Alfaro V, Soto-Matos A, Fernández-Teruel C, Siguero M, Tabernero JM, Paz-Ares L, de Bono JS, López-Martin JA.
Yap TA, et al. Among authors: de bono js.
Br J Cancer. 2012 Apr 10;106(8):1379-85. doi: 10.1038/bjc.2012.99.
Br J Cancer. 2012.
PMID: 22491421
Free PMC article.
Clinical Trial.